ELUCENIA
Skip to content
ELUCENIA

ELUCENIA / Sources and references

Sources and references · Page 5

Explore the literature and resources supporting ELUCENIA pages and tools, with links to the context in which each source appears.

Editorial update · October 6, 2026

Index of the documents, databases, methods and resources cited on the site. Each record shows where it is used. Inclusion does not imply an institutional partnership or endorsement of all source content.

4483 records

Literature and references

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-trial-endpoints-approval-cancer-drugs-and-biologics

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-trial-endpoints-approval-cancer-drugs-and-biologics
Used in (7)Overall survivalSurrogate endpointProgression-free survivalWhat does an early-phase study reveal about dose and safety?How should oncology trial endpoints be interpreted?How can quality of life be studied beyond tumour control?Hazard ratio
Literature and references

https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment

https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment
Used in (6)How does a tumour variant differ from an inherited variant?How can we investigate why a treatment stops controlling a tumour?Why do people with similar tumours respond differently to immunotherapy?How can we tell whether a biomarker predicts treatment benefit?Circulating tumour DNA (ctDNA)Predictive biomarker

What would you like to understand?

Search brings together public editorial content and tools. Results retain their review status.